The effect of consolidation chemotherapy after concurrent chemoradiotherapy on the survival of patients with locally advanced non-small cell lung cancer: a meta-analysis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The effect of consolidation chemotherapy after concurrent chemoradiotherapy on the survival of patients with locally advanced non-small cell lung cancer: a meta-analysis
Authors
Keywords
Non-small cell lung cancer, Chemoradiotherapy, Consolidation chemotherapy, Meta-analysis
Journal
International Journal of Clinical Oncology
Volume 22, Issue 2, Pages 229-236
Publisher
Springer Nature
Online
2016-12-22
DOI
10.1007/s10147-016-1074-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Consolidation chemotherapy may improve survival for patients with locally advanced non-small-cell lung cancer receiving concurrent chemoradiotherapy - retrospective analysis of 203 cases
- (2015) Lipin Liu et al. BMC CANCER
- Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non–Small-Cell Lung Cancer: KCSG-LU05-04
- (2015) Jin Seok Ahn et al. JOURNAL OF CLINICAL ONCOLOGY
- The Optimal Treatment Modality in Patients with T4N2M0 Non-Small Cell Lung Cancer: The Best Choice May Be Definitive Chemoradiotherapy Followed by Consolidation Chemotherapy
- (2015) Hasan Mutlu et al. CHEMOTHERAPY
- Treatment of Stage III Non-small Cell Lung Cancer
- (2013) Nithya Ramnath et al. CHEST
- Is Consolidation Chemotherapy after Concurrent Chemo-Radiotherapy Beneficial for Patients with Locally Advanced Non–Small-Cell Lung Cancer?: A Pooled Analysis of the Literature
- (2013) Kazuyuki Tsujino et al. Journal of Thoracic Oncology
- Long-term results of concurrent chemoradiotherapy using cisplatin and vinorelbine for stage III non-small-cell lung cancer
- (2012) Hidehito Horinouchi et al. CANCER SCIENCE
- Unmet Challenges in the Use of Novel Agents in Locally Advanced Non–Small-Cell Lung Cancer
- (2012) Roy H. Decker et al. JOURNAL OF CLINICAL ONCOLOGY
- Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
- (2012) Julian R. Molina et al. MAYO CLINIC PROCEEDINGS
- Updated survival and outcomes for older adults with inoperable stage III non-small-cell lung cancer treated with cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel: analysis of a phase III trial from the Hoosier Oncology Group (HOG) and US Oncology
- (2011) S. I. Jalal et al. ANNALS OF ONCOLOGY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Maintenance Therapy With Continuous or Switch Strategy in Advanced Non-small Cell Lung Cancer
- (2011) Xinji Zhang et al. CHEST
- Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410
- (2011) W. J. Curran et al. JNCI-Journal of the National Cancer Institute
- Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
- (2010) Anne Aupérin et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy and Toxicity of Chemoradiotherapy with Carboplatin and Irinotecan Followed by Consolidation Docetaxel for Unresectable Stage III Non-small Cell Lung Cancer
- (2010) Bruno R. Bastos et al. Journal of Thoracic Oncology
- Duration of Chemotherapy for Advanced Non–Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized Trials
- (2009) Yu Yang Soon et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study of Cisplatin, Etoposide, and Concurrent Chest Radiation With or Without Consolidation Docetaxel in Patients With Inoperable Stage III Non–Small-Cell Lung Cancer: The Hoosier Oncology Group and U.S. Oncology
- (2008) Nasser Hanna et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started